Le Lézard
Classified in: Environment, Covid-19 virus
Subjects: Product/Service, Nonprofit

Oshkosh Corporation Details Progress With 2021 Sustainability Report


Oshkosh Corporation (NYSE:OSK), a leading innovator of mission-critical vehicles and essential equipment has released its ninth annual Sustainability Report, reinforcing the Company's continued focus on innovation, commitment to sustainable business practices and building a better world.

Oshkosh Corporation's sustainability strategy is guided by four core areas: empowering our people, developing innovative products, building communities and operating sustainably. Throughout 2021, the Company made positive strides in all areas, including being awarded the United States Postal Service contract for the Next Generation Delivery Vehicle (NGDV), replacing its fleet of delivery trucks with new electric or low-emission internal combustion engine vehicles. Additionally, the Company reinforced its commitment with the CEO Action for Diversity & Inclusion Coalition, dedicating time through their Racial Equity Fellowship program and progressed on crucial sustainability targets.

"At Oshkosh Corporation, we are committed to people and our planet. We continue to strive towards a more sustainable future by investing in our team members, our communities and advancing technologies," said Kevin Tubbs, Oshkosh Corporation vice president, chief ethics, compliance and sustainability officer. "As we deliver zero-emission electrified products across our markets, give back to the communities where we live and work and continue our focus on improving sustainable operations, we remain steadfast in our commitment to innovating for a better world."

Highlights from the Sustainability Report include:

In addition to being named one of the World's Most Ethical Companies, Oshkosh Corporation is listed on the Dow Jones Sustainability World Index, has repeatedly been named as one of Barron's "100 Most Sustainable Companies", and is considered one of FORTUNE's World's Most Admired Companies.

To learn more, and access the fiscal year 2021 Sustainability Report, please click here: https://www.oshkoshcorp.com.

About Oshkosh Corporation

At Oshkosh (NYSE: OSK), we make innovative, mission-critical equipment to help everyday heroes advance communities around the world. Headquartered in Wisconsin, Oshkosh Corporation employs approximately 15,000 team members worldwide, all united behind a common cause: to make a difference in people's lives. Oshkosh products can be found in more than 150 countries under the brands of JLG®, Pierce®, Oshkosh® Defense, McNeilus®, IMT®, Jerr-Dan®, Frontlinetm, Oshkosh® Airport Products, Londontm and Pratt Miller. For more information, visit oshkoshcorp.com.

®, tm All brand names referred to in this news release are trademarks of Oshkosh Corporation or its subsidiary.

Forward Looking Statements

This Proxy Statement contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including, without limitation, statements regarding the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations, are forward-looking statements. When used in this Proxy Statement, words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "project" or "plan" or the negative thereof or variations thereon or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, assumptions and other factors, some of which are beyond the Company's control, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors include the extent of supply chain and logistics disruptions, particularly as demand rebounds from the effects of the COVID-19 pandemic; the Company's ability to increase prices or impose surcharges to raise margins or to offset higher input costs, including increased raw material, labor and freight costs; the cyclical nature of the Company's access equipment, commercial and fire & emergency markets, which are particularly impacted by the strength of U.S. and European economies and construction seasons; the Company's estimates of access equipment demand which, among other factors, is influenced by historical customer buying patterns and rental company fleet replacement strategies; the Company's ability to attract production labor in a timely manner; the strength of the U.S. dollar and its impact on Company exports, translation of foreign sales and the cost of purchased materials; the Company's ability to predict the level and timing of orders for indefinite delivery/indefinite quantity contracts with the U.S. federal government; risks related to reductions in government expenditures in light of U.S. defense budget pressures and an uncertain U.S. Department of Defense (DoD) tactical wheeled vehicle strategy; the impact of any DoD solicitation for competition for future contracts to produce military vehicles; the impacts of budget constraints facing the USPS and continuously changing demands for postal services; the impact of severe weather, natural disasters or pandemics that may affect the Company, its suppliers or its customers; risks related to the collectability of receivables, particularly for those businesses with exposure to construction markets; the cost of any warranty campaigns related to the Company's products; risks associated with international operations and sales, including compliance with the Foreign Corrupt Practices Act; risks that a trade war and related tariffs could reduce the competitiveness of the Company's products; the Company's ability to comply with complex laws and regulations applicable to U.S. government contractors; cybersecurity risks and costs of defending against, mitigating and responding to data security threats and breaches impacting the Company; the Company's ability to successfully identify, complete and integrate acquisitions and to realize the anticipated benefits associated with the same; and risks related to the Company's ability to successfully execute on its strategic road map and meet its long-term financial goals. Additional information concerning these and other factors is contained in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K filed on November 16, 2021. All forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and disclaims any obligation, to update information contained in this document. Investors should be aware that the Company may not update such information until the Company's next quarterly earnings conference call, if at all.


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: